Self administration of topical steroids in face: A cross-sectional study from a tertiary care hospital in Northeast India

---

Original Article

Author Details : Shromona Kar*, Bhaskar Gupta, Gazala Khanam Barbhuiya

Volume : 8, Issue : 2, Year : 2022

Article Page : 118-123

https://doi.org/10.18231/j.ijced.2022.026

Suggest article by email

Get Permission

---

Abstract

Background: Topical steroid (TS) creams are easily available in pharmacies all over India, as OTC (over the counter) drugs. So are easily being misused even without the dermatologist’s prescription, which leads to side effects pertaining to the lack of awareness about the contraindications and adverse effects of the topical steroids.
Materials and Methods: This was a cross-sectional, questionnaire-based study, conducted from July 2021 to December 2021, at the outpatient Department of Dermatology, Venereology and Leprosy, of a tertiary care hospital in North East India. Patients of both sexes (males and females), 15 years onwards were included in this study who presented with any kind of facial dermatoses resulting from use of topical steroid on face.
Results: Out of 300 patients who misused TS, majority were females (72%). The most common brand used was Betnovate C which contained betamethasone (0.1% w/w) & clioquinol (3% w/w). The average duration of use was less than 6 months (51%), shortest being 15 days and longest being 4 years. The most common reason for misuse was acne (38%) followed by fairness (22%) and the most common effect observed after misuse was acne form eruptions (25%) followed by dyspigmentation (16%). Most of the users had attained education till primary school. Abuse was commonly from purchase of the drug OTC or from pharmacists.
Conclusion: As steroid abuse is increasing alarmingly, awareness about its various adverse effects becomes necessary.
 
Keywords: TSDF, OTC, FAIRNESS, Steroid abuse

How to cite : Kar S, Gupta B, Barbhuiya G K, Self administration of topical steroids in face: A cross-sectional study from a tertiary care hospital in Northeast India. IP Indian J Clin Exp Dermatol 2022;8(2):118-123

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.